Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rewald

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Transfusion Science|November 4, 1995
Are there options for donor-derived i.m. anti-D IgG preparations other than to prevent Rh(D) sensitization? The intravenous routeE Rewald
Lancet (London, England)|September 28, 1974
Letter: B.C.G. in rheumatoid arthritisE Rewald
Lancet (London, England)|October 3, 1987
Repeated low doses of anti-rhesus gammaglobulin in aplastic anaemiaE Rewald
Transfusion Science|October 18, 2000
IVIG as a nonspecific accelerator of restitutio ad integrumE Rewald
Sangre|January 1, 1975
[Letterer-Christian's disease (histiocytosis X)]E Rewald
Medical Hypotheses|November 1, 1990
A vascular effect of IgG therapy may prevent transplacental red cell leakage and spontaneous thrombocytopenic haemorrhagesE Rewald
The Journal of Sports Medicine and Physical Fitness|August 7, 2013
Improved work capacity at altitude by transfusional polycythemiaE Rewald
Transfusion Science|March 21, 2000
Antifibrotic tendency as complement to inflammatory burnout? Six year IVIG treatment in a case with atherosclerosis and chronic hepatitis CE Rewald
Sangre|January 1, 1977
[Well tolerated neutropenia and monocytopenia (author's transl)]E Rewald
Lancet (London, England)|July 27, 1985
Intravenous gammaglobulin to prevent stillbirth in rhesus incompatibilityE Rewald
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Transfusion Science|November 4, 1995
Are there options for donor-derived i.m. anti-D IgG preparations other than to prevent Rh(D) sensitization? The intravenous routeE Rewald
Lancet (London, England)|September 28, 1974
Letter: B.C.G. in rheumatoid arthritisE Rewald
Lancet (London, England)|October 3, 1987
Repeated low doses of anti-rhesus gammaglobulin in aplastic anaemiaE Rewald
Transfusion Science|October 18, 2000
IVIG as a nonspecific accelerator of restitutio ad integrumE Rewald
Sangre|January 1, 1975
[Letterer-Christian's disease (histiocytosis X)]E Rewald
Medical Hypotheses|November 1, 1990
A vascular effect of IgG therapy may prevent transplacental red cell leakage and spontaneous thrombocytopenic haemorrhagesE Rewald
The Journal of Sports Medicine and Physical Fitness|August 7, 2013
Improved work capacity at altitude by transfusional polycythemiaE Rewald
Transfusion Science|March 21, 2000
Antifibrotic tendency as complement to inflammatory burnout? Six year IVIG treatment in a case with atherosclerosis and chronic hepatitis CE Rewald
Sangre|January 1, 1977
[Well tolerated neutropenia and monocytopenia (author's transl)]E Rewald
Lancet (London, England)|July 27, 1985
Intravenous gammaglobulin to prevent stillbirth in rhesus incompatibilityE Rewald
Pageof 3